Loading...

SOHO 2026 Annual Meeting

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Beyond Platelet Transfusions: Romiplostim Reduces Chemotherapy Dose Modifications in Chemotherapy-Induced Thrombocytopenia: A Meta-Analysis of Randomized Controlled Trials

MDS - 1188

Beyond Platelet Transfusions: Romiplostim Reduces Chemotherapy Dose Modifications in Chemotherapy-Induced Thrombocytopenia: A Meta-Analysis of Randomized Controlled Trials

Hany Dawoud

Poster Presenter: Hany Dawoud

Thumbnail for Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

MDS - 1210

Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

Alex Bataller

Poster Presenter: Alex Bataller

Thumbnail for Concurrent DDX41 and TP53 Alterations in Myeloid Neoplasms: Single-Institution Real-World Clonal Dynamics and Outcomes

MDS - 1254

Concurrent DDX41 and TP53 Alterations in Myeloid Neoplasms: Single-Institution Real-World Clonal Dynamics and Outcomes

Ekrem Turk

Poster Presenter: Ekrem Turk

Thumbnail for Comparative Outcomes With Luspatercept Versus Erythropoiesis-Stimulating Agents in Lower-Risk Myelodysplastic Syndromes: A Propensity Score-Matched Retrospective Cohort Study

MDS - 1271

Comparative Outcomes With Luspatercept Versus Erythropoiesis-Stimulating Agents in Lower-Risk Myelodysplastic Syndromes: A Propensity Score-Matched Retrospective Cohort Study

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

MDS - 1284

Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

Sooraj Srirangadhamu Gopu

Poster Presenter: Sooraj Srirangadhamu Gopu

Thumbnail for Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score-Matched TriNetX Analysis

MDS - 1298

Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score-Matched TriNetX Analysis

Kofi Boakye Opoku

Poster Presenter: Kofi Boakye Opoku

Thumbnail for Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

MDS - 1311

Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Randomized Treatments for Myelodysplastic Syndrome and Related Disorders: A Comprehensive Component Network Meta-Analysis of Randomized Controlled Trials

MDS - 1343

Randomized Treatments for Myelodysplastic Syndrome and Related Disorders: A Comprehensive Component Network Meta-Analysis of Randomized Controlled Trials

Emi Zerzan

Poster Presenter: Emi Zerzan

Thumbnail for Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

MDS - 1364

Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

Yagna Priya Chirrareddy

Poster Presenter: Yagna Priya Chirrareddy